CUBIST PHARMACEUTICALS INC — key financial figures for fiscal year 2013 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2013)

$1.1B

Net Income/Loss (FY2013)

-$18.6M

Total Assets (FY2013)

$3.1B

Total Equity (FY2013)

$1.4B

Cash Flows from Operating Activities (FY2013)

$16.4M

Source: CUBIST PHARMACEUTICALS INC 10-K filing (FY2013). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.